New Key Statistics Module, Z-Score and F-Score
NYSE:TARO Key Ratios
Market Cap $ M | 1,583.82 |
Enterprise Value $ M | 737.73 |
P/E(ttm) | 34.54 |
PE Ratio without NRI | 34.60 |
Forward PE Ratio | -- |
Price/Book | 0.89 |
Price/Sales | 2.60 |
Price/Free Cash Flow | 18.41 |
Price/Owner Earnings | 13.28 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 610.00 |
EPS (TTM) $ | 1.22 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 527.70 |
EV-to-EBIT | 16.87 |
EV-to-EBITDA | 9.53 |
PEG | -- |
Shares Outstanding M | 37.58 |
Net Margin (%) | 7.48 |
Operating Margin % | 3.60 |
Pre-tax Margin (%) | 12.17 |
Quick Ratio | 3.03 |
Current Ratio | 3.60 |
ROA % (ttm) | 2.14 |
ROE % (ttm) | 2.61 |
ROIC % (ttm) | 1.13 |
Dividend Yield % | -- |
Altman Z-Score | 3.42 |
TARO Number of Guru Trades
TARO Volume of Guru Trades
Gurus Latest Trades with NYSE:TARO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:TARO is held by these investors
Total 1
Taro Pharmaceutical Industries Ltd Insider Transactions
No Available Data
News about NYSE:TARO
Total 0- 1